Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-078507
Filing Date
2025-08-19
Accepted
2025-08-19 16:18:43
Documents
59
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0251232-10q_apimeds.htm   iXBRL 10-Q 547565
2 AMENDMENT TO MAY 2024 PROMISSORY NOTE BY AND BETWEEN APIMEDS PHARMACEUTICALS US, ea025123201ex10-1_apimeds.htm EX-10.1 5457
3 AMENDMENT TO AUGUST 2024 PROMISSORY NOTE BY AND BETWEEN APIMEDS PHARMACEUTICALS ea025123201ex10-2_apimeds.htm EX-10.2 6143
4 AMENDMENT TO MARCH 2025 PROMISSORY NOTE BY AND BETWEEN APIMEDS PHARMACEUTICALS U ea025123201ex10-3_apimeds.htm EX-10.3 6120
5 CERTIFICATION ea025123201ex31-1_apimeds.htm EX-31.1 9313
6 CERTIFICATION ea025123201ex31-2_apimeds.htm EX-31.2 9315
7 CERTIFICATION ea025123201ex32-1_apimeds.htm EX-32.1 3231
8 CERTIFICATION ea025123201ex32-2_apimeds.htm EX-32.2 3241
  Complete submission text file 0001213900-25-078507.txt   4050288

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE apus-20250630.xsd EX-101.SCH 33913
10 XBRL CALCULATION FILE apus-20250630_cal.xml EX-101.CAL 23051
11 XBRL DEFINITION FILE apus-20250630_def.xml EX-101.DEF 184491
12 XBRL LABEL FILE apus-20250630_lab.xml EX-101.LAB 346602
13 XBRL PRESENTATION FILE apus-20250630_pre.xml EX-101.PRE 198122
61 EXTRACTED XBRL INSTANCE DOCUMENT ea0251232-10q_apimeds_htm.xml XML 404684
Mailing Address 100 MATAWAN RD SUITE 325 MATAWAN NJ 07747
Business Address 100 MATAWAN RD SUITE 325 MATAWAN NJ 07747 848-201-5010
Apimeds Pharmaceuticals US, Inc. (Filer) CIK: 0001894525 (see all company filings)

EIN.: 851099700 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42545 | Film No.: 251232040
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)